Journals Higher Education



This item is out of stock. It can be ordered now and is due to ship on 05 April 2022.

Notify Me When In Stock

Published: 29 April 2022

240 Pages | 5 line illus.

6 1/8 x 9 1/4 inches

ISBN: 9780195084009

Also Available As:


Also Available In:

Bookseller Code (01)

From Breakthrough to Blockbuster

The Business of Biotechnology

Donald L. Drakeman, Lisa N. Drakeman, and Nektarios Oraiopoulos

  • Tells the exciting story of disruptive technologies giving birth to a new industry of biotech companies competing with Big Pharma
  • Details how biotech entrepreneurs succeeded in creating the most breakthrough medicines of the past two decades with the latest academic research
  • Explains the expensive, time-consuming, and highly regulated bench-to-bedside biomedical R&D process in accessible language
  • Highlights the importance of ensuring that the entire biotech ecosystem, including academic research, investors, and the pharmaceutical industry, continues to thrive
  • Authored by CEOs of successful US and European biotech companies, one of which pioneered the development of the checkpoint inhibitor cancer treatments recognized in the Nobel Prize for Medicine 2018

Also of Interest